Holen Sie sich die Stockscreener-App
1.86
2.11%
-0.04
Schlusskurs vom Vortag:
$1.90
Offen:
$1.9
24-Stunden-Volumen:
405.60K
Relative Volume:
0.49
Marktkapitalisierung:
$118.52M
Einnahmen:
$198.53M
Nettoeinkommen (Verlust:
$-63.68M
KGV:
-1.8196
EPS:
-1.0222
Netto-Cashflow:
$-41.50M
1W Leistung:
-17.70%
1M Leistung:
-31.37%
6M Leistung:
-73.04%
1J Leistung:
-81.55%
1-Tages-Spanne:
$1.86
$1.965
1-Wochen-Bereich:
$1.86
$2.305
52-Wochen-Spanne:
$1.86
$10.30
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
1.86 | 121.06M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
112.68 | 193.83B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
366.05 | 140.01B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
99.49 | 129.33B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
BSX
Boston Scientific Corp
|
74.73 | 109.92B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
75.87 | 44.36B | 6.07B | 1.06B | 799.60M | 1.8527 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-07 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-11-07 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-12-31 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-08 | Herabstufung | Truist | Buy → Hold |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
| 2022-05-12 | Eingeleitet | BTIG Research | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating a Potential 121% Upside in the Healthcare Sector - DirectorsTalk Interviews
Treace Medical Concepts to Release Q4 and Full Year 2025 Financial Results - Intellectia AI
Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026 - Bitget
Treace Medical Concepts to Release Fourth Quarter and Full Year 2025 Financial Results on February 27, 2026 - Quiver Quantitative
Why is Treace Medical Concepts Inc stock going up2025 Retail Activity & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Stockholders to Connect - ACCESS Newswire
Stifel Revises Treace Medical Concepts, Inc. (TMCI) Price Target in Sector-Wide Update - Finviz
11 High Growth Micro-cap Stocks to Buy - Insider Monkey
Treace Medical Concepts (NASDAQ:TMCI) Upgraded at Wall Street Zen - MarketBeat
Johnson Fistel, PLLP Investigates Claims on Behalf of - GlobeNewswire
Institutional owners may consider drastic measures as Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) recent US$29m drop adds to long-term losses - simplywall.st
301,100 Shares in Treace Medical Concepts, Inc. $TMCI Acquired by Acuitas Investments LLC - Defense World
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Connect - accessnewswire.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Treace Medical Concepts, Inc. (TMCI) And Encourages Shareholders to Reach Out - ACCESS Newswire
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring A Potential 81% Upside - DirectorsTalk Interviews
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Average Rating of "Reduce" from Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Treace Medical Concepts sees revenue fall in the fourth quarter - Jacksonville Daily Record
How New Analyst Targets Are Reframing The Treace Medical Concepts (TMCI) Investment Story - Yahoo Finance
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Treace Medical Concepts, Inc. (TMCI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Treace Medical Concepts Reports Q3 2025 Financial Results - MSN
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Critical Analysis: Treace Medical Concepts (NASDAQ:TMCI) versus Adagio Medical (NASDAQ:ADGM) - Defense World
Treace Medical Concepts, Inc. (TMCI): Investor Outlook Highlights 83.77% Potential Upside - DirectorsTalk Interviews
Downgrade Watch: Will Treace Medical Concepts Inc stock hit new highs in YEARJuly 2025 Highlights & Detailed Earnings Play Alerts - baoquankhu1.vn
Treace Medical Concepts’ preliminary revenue down 9% in Q4 2025 - Medical Buyer
Treace Medical Issues Preliminary Q4 Results, Highlights Growth - TipRanks
Treace Medical Concepts, Inc. Provides Preliminary Revenue for the Fourth Quarter of 2025 - marketscreener.com
Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue - The Manila Times
Treace Medical Concepts Reports Preliminary 2025 Revenue Results and Updates on Surgeon Adoption Trends - Quiver Quantitative
Published on: 2026-01-13 05:27:40 - ulpravda.ru
Bronstein, Gewirtz & Grossman, LLC Encourages Treace Medical Concepts, Inc. (TMCI) Investors to Inquire about Securities Investigation - ACCESS Newswire
How Treace Medical Concepts Inc. stock compares to industry benchmarksAnalyst Downgrade & Advanced Technical Analysis Signals - ulpravda.ru
Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - The Manila Times
Will Treace Medical Concepts Inc. stock recover faster than market2025 Valuation Update & Growth Oriented Trade Recommendations - Улправда
Will Treace Medical Concepts Inc. stock return to pre crisis levels2025 Pullback Review & AI Optimized Trading Strategy Guides - ulpravda.ru
Will Treace Medical Concepts Inc. stock outperform Nasdaq indexDollar Strength & High Accuracy Swing Entry Alerts - Улправда
Dow Theory LettersTreace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology - FinancialContent
Is Treace Medical Concepts Inc. stock oversold or undervaluedMarket Activity Report & Accurate Intraday Trade Tips - Улправда
How Treace Medical Concepts Inc. stock reacts to Fed rate cutsJuly 2025 Spike Watch & Precise Buy Zone Identification - Улправда
How Treace Medical Concepts Inc. stock benefits from tech adoptionJuly 2025 Update & Breakout Confirmation Alerts - Улправда
The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts - Benzinga
Why Investors Shouldn't Be Surprised By Treace Medical Concepts, Inc.'s (NASDAQ:TMCI) Low P/S - simplywall.st
How Recent Guidance Shifts Are Rewriting The Story For Treace Medical Concepts (TMCI) - Yahoo Finance
How Treace Medical Concepts Inc. stock performs during Fed tightening cycles2026 world cup usa national team round of 16 goalkeepers transition play odds analysis tactical review - Улправда
Treace Medical’s Earnings Call: Growth Amid Challenges - MSN
Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Exploring a 115% Potential Upside Amidst Market Challenges - DirectorsTalk Interviews
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Treace Medical Concepts CEO John T. Treace to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Bunion-focused medtech CEO to speak at J.P. Morgan Healthcare Conference - Stock Titan
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.33%
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):